Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-07-20
2010-11-23
Kim, Jennifer M (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S276000, C514S350000, C514S356000, C514S561000
Reexamination Certificate
active
07838526
ABSTRACT:
Essential tremor can effectively be treated with high doses of Riboflavin (vitamin B2), either on its own or coupled with one or more other B vitamins and/or coenzyme Q10 (CoQ10). The treatment constitutes a significant improvement over prior treatment methods in that it not only alleviates essential tremor, but results in better performance of the affected body portion and may delay the progression of the disease. The preferred addition of other B vitamins and/or CoQ10 also provides balance to the nutrient energy requirements of a patient's body.
REFERENCES:
patent: 4491594 (1985-01-01), Ogawa
patent: 4499064 (1985-02-01), Shive
patent: 4500524 (1985-02-01), Catsimpoolas
patent: 4806354 (1989-02-01), Green
patent: 5053396 (1991-10-01), Blass
patent: 5095115 (1992-03-01), Grimmer et al.
patent: 5776783 (1998-07-01), Kell
patent: 5885976 (1999-03-01), Sandyk
patent: 6068981 (2000-05-01), Rittenburg et al.
patent: 6136801 (2000-10-01), Kell
patent: 6395299 (2002-05-01), Babich et al.
patent: 6500450 (2002-12-01), Hendrix
patent: 6514544 (2003-02-01), Fuchs et al.
patent: 6589994 (2003-07-01), Artman et al.
patent: 6835750 (2004-12-01), Henderson
patent: 7273884 (2007-09-01), Shellenberger
patent: 2002/0198177 (2002-12-01), Horrobin
patent: 2003/0012825 (2003-01-01), Kapper
patent: 2004/0111129 (2004-06-01), Gliner et al.
patent: 2004/0142992 (2004-07-01), Shellenberger
patent: 2004/0225198 (2004-11-01), Kazantseva
patent: 2005/0038092 (2005-02-01), Fukuda
patent: 2005/0119315 (2005-06-01), Fedida
patent: 2005/0249823 (2005-11-01), Murphy et al.
Stern Pathophysiology of rest tremor Proc. Int. Cong. Neuro-Genet. Neuro-Ophthalmol. World Fed. Neurol., 2nd(1969), meeting date 1967, vol. 1, pp. 386-389 , abstract.
Langhor et al. Vitamin B1, B2 and B6 deficiency in neurological disorders, Journal of Neurology, Apr. 1981, vol. 225, No. 2, pp. 1432-1459,Germany.
Stolze et al. The gait disorder of advanced essential tremor. Brain. Nov. 2001, vol. 124, No. 11, pp. 2278-2286, especially p. 2284, lines 4-7.
Balbisi, Ebrahim et al., “Riboflavin in Prophylactic Treatment of Migraine”, U.S. Pharmacist , May 16, 2006, 5:32-38,Vo. No. 30:05,—a Jobson Publication,Bloomfield, NJ.
Coimbra CG et al., “High Doses of Riboflavin and the Elimination of Red Meat . . . ”,Pub Med, Braz J Med Biol Res. Oct. 2003, 1409-17 ,36(10), Ribeirão Preto SP Brasil.
Sandor PS et al., Prophylactic Treatment of Migraine with Beta-Blockers . . . , Pub Med, Headache.Jan. 2000; 30-5, 40 (1), Neurology Dept., CHR Citadelle, Univ. of Leige, Belgium.
Bodner, Ruth A. et al., “Pharmacological Promotion of Inclusion . . . ”, PNAS, Mar. 14, 2006, 4246-4251, vol. 103, No. 11, online + Linthicum, MD.
Mayo Clinic, “Treatment of Essential Tremor at Mayo Clinic in Jacksonville, FL”, 2005, Mayo Clinic, Jacksonville, Fla.
The Cleveland Clinic Health Information Center, “Drug Treatments for Essential Tremor”, The Cleveland Clinic, 2004, Cleveland, Ohio.
McCormick, D.B.. et al., “Ribovlavin”, the American Society for Nutritional Sciences (nutrition.org), 2005.
International Essential Tremor Foundation, “Coping With Essential Tremor”, (www.essentialtremor.org),2005, Lenexa, Kansas.
WHYVITAMINS.COM, “Vitamin B2-Riboflavin”, 2003.
SPRINGBOARD4HEALTH.COM, “Vitamin B-2”, 2004.
CLAROCET.COM, “Essential-b Complex” 2005, Medicor Labs Corp.
University of Maryland Medical Center (www.umm.edu), “Coenzyme Q10”, 2004, Baltimore, MD.
NETFIT.CO.UK “Vitamin B”, 2006.
National Cancer Institute (www.cancer.gov), “Questions and Answers About Coenzyme Q10”, 2006, Bethesda, MD.
HOWSTUFFWORKS .COM, “How B Vitamins Work”, 2006, Atlanta, GA.
Vitacost (vitacost.com), “Pantothenic Acid”, 2006, Boynton Beach, FL.
Essense of Life ,(essense-of-life.com) “Vitamin B”, 2005.
Bates, CJ et al., “Biochemical Indices and Neuromuscular Function Tests . . . ”,BR J Nutr, 1994, 601-10, 72(4), Oxfordshire, U.K.
Haralambie G., “Vitamin B2 status in athletes and the influence of riboflavin . . . ”, (inforetrieve.com) Nutr Metab., 1976, 1-8, 20(1), BioMed Central.
Baker, SK et al., “Targeting Cellular Energy Production in Neurological Disorders”, (infrotreive.com) Expert Opin Investig Drugs, 2003, -1655-79, 12(10).
National Cancer Institute, “Coenzyme Q10 (PDQ)”, 2005, www.cancer. gov.
Bates et al., “Biochemical indices and neuromuscular function tests in rural Gambian schoolchildren . . . ”, [Pub Med.—NCBI] Br. J. Nutr., Oct. 1994, pp. 601-610, 72 (4).
Lieberman, “Dr. Lieberman Answers Your Questions, Are Vitamins Good for PD?”, 2005, Lieberman Parkinson Clinic, North Bay Village, FL [www.liebermanparkinsonclinic.com].
WholeHealthMD.com, “Riboviavin (Vitamin B2)”, 2000, WholeHealthMD , Sterling VA, [WholeHealthMD.com].
Gottlieb Rackman & Reisman
Kim Jennifer M
LandOfFree
Method of treating neurological disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating neurological disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating neurological disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4187339